Published in Ann Intern Med on September 16, 2008
COPD Assessment and Management Bundle Versus Usual Care | NCT01833026
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis (2009) 1.52
The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest (2014) 1.51
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Tiotropium HandiHaler in the treatment of COPD: a safety review. Int J Chron Obstruct Pulmon Dis (2009) 1.32
Safety of indacaterol in the treatment of patients with COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.19
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India (2013) 1.13
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open (2012) 1.13
Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD (2011) 1.06
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 1.02
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis. Int J Chron Obstruct Pulmon Dis (2015) 0.99
Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol (2015) 0.98
Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines. Basic Clin Pharmacol Toxicol (2015) 0.97
Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.95
Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date. Ther Adv Drug Saf (2012) 0.94
A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD. BMJ Open (2012) 0.93
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review. Wien Klin Wochenschr (2009) 0.91
Safety, tolerability and risk benefit analysis of tiotropium in COPD. Int J Chron Obstruct Pulmon Dis (2008) 0.89
Optimising treatment for COPD--new strategies for combination therapy. Int J Clin Pract (2009) 0.87
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. Int J Chron Obstruct Pulmon Dis (2009) 0.85
Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links. Biomed Res Int (2014) 0.85
Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma. J Asthma (2014) 0.84
The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Respir Res (2010) 0.84
Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. Br J Clin Pharmacol (2014) 0.84
Safety and tolerability of inhalational anticholinergics in COPD. Drug Healthc Patient Saf (2013) 0.82
Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study. Lung (2014) 0.80
Predictors for mortality in hospitalized patients with chronic obstructive pulmonary disease. Springerplus (2014) 0.80
Body mass index and causes of death in chronic kidney disease. Kidney Int (2016) 0.80
Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD--role of umeclidinium/vilanterol. Int J Chron Obstruct Pulmon Dis (2014) 0.79
Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis. PLoS One (2015) 0.78
Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Optimizing safety of COPD treatments: role of the nurse practitioner. J Multidiscip Healthc (2013) 0.77
Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.76
Nebulized formoterol: a review of clinical efficacy and safety in COPD. Int J Chron Obstruct Pulmon Dis (2010) 0.76
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome? Ann Intern Med (2009) 0.75
Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population. Medicine (Baltimore) (2015) 0.75
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome? Ann Intern Med (2009) 0.75
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome? Ann Intern Med (2009) 0.75
Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage. Exp Ther Med (2016) 0.75
Managing multimorbidity in primary care in patients with chronic respiratory conditions. NPJ Prim Care Respir Med (2016) 0.75
Pragmatic research and outcomes in asthma and COPD. Pragmat Obs Res (2012) 0.75
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med (2007) 6.14
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol (2004) 4.17
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 4.15
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Development, Testing, and Implementation of the ACGME Clinical Learning Environment Review (CLER) Program. J Grad Med Educ (2012) 3.98
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2007) 3.17
Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2007) 3.14
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health (2012) 3.14
Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med (2007) 3.03
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD (2005) 2.66
Improving clinical learning environments for tomorrow's physicians. N Engl J Med (2014) 2.61
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res (2012) 2.50
Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med (2006) 2.49
Cardiovascular events associated with ipratropium bromide in COPD. Chest (2009) 2.36
The cost-effectiveness of an inner-city asthma intervention for children. J Allergy Clin Immunol (2002) 2.27
Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med (2014) 2.08
Alcohol screening scores and medication nonadherence. Ann Intern Med (2008) 1.94
The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med (2002) 1.92
CLER Pathways to Excellence: Expectations for an Optimal Clinical Learning Environment (Executive Summary). J Grad Med Educ (2014) 1.92
A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med (2006) 1.91
Mortality rate in veterans with multiple chronic conditions. J Gen Intern Med (2007) 1.89
Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2004) 1.86
Transitions of Care Consensus Policy Statement American College of Physicians-Society of General Internal Medicine-Society of Hospital Medicine-American Geriatrics Society-American College of Emergency Physicians-Society of Academic Emergency Medicine. J Gen Intern Med (2009) 1.79
Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. Ann Intern Med (2004) 1.78
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med (2003) 1.77
Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis (2005) 1.74
Evaluating physician performance at individualizing care: a pilot study tracking contextual errors in medical decision making. Med Decis Making (2007) 1.74
The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med (2003) 1.74
The accreditation system after the "next accreditation system". Acad Med (2014) 1.72
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Fam Med (2007) 1.72
A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69
Comparative effectiveness research: Relevance and applications to pharmacy. Am J Health Syst Pharm (2009) 1.69
Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.68
Improving childhood asthma outcomes in the United States: a blueprint for policy action. Pediatrics (2002) 1.67
The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol (2006) 1.64
A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Arch Pediatr Adolesc Med (2005) 1.63
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62
Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol (2003) 1.57
The protective effect of community factors on childhood asthma. J Allergy Clin Immunol (2009) 1.55
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Fam Med (2007) 1.54
Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med (2005) 1.54
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.53
Impact of NSAIDS on mortality and the effect of preexisting coronary artery disease in US veterans. Am J Med (2007) 1.52
Regional variation in health status among chronic obstructive pulmonary disease patients. Respiration (2010) 1.52
Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52
The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest (2014) 1.51
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respir Care (2009) 1.46
Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2004) 1.45
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med (2010) 1.45
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol (2004) 1.44
Asthma morbidity and treatment in the Chicago metropolitan area: one decade after national guidelines. Ann Allergy Asthma Immunol (2005) 1.44
Advances in the ACGME Clinical Learning Environment Review (CLER) Program. J Grad Med Educ (2013) 1.44
Spirometry use in clinical practice following diagnosis of COPD. Chest (2006) 1.43
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med (2005) 1.41
The Methodology for the CLER National Report of Findings 2016. J Grad Med Educ (2016) 1.39
Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med (2003) 1.33
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer (2005) 1.33
Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med (2012) 1.33
Visual analog scales for assessing surgical pain. J Am Coll Surg (2005) 1.32
Variations in asthma care by race/ethnicity among children enrolled in a state Medicaid program. Pediatrics (2004) 1.32
Geographic variability in childhood asthma prevalence in Chicago. J Allergy Clin Immunol (2008) 1.31
The Overview of the CLER Program: CLER National Report of Findings 2016. J Grad Med Educ (2016) 1.31
Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol (2010) 1.30
A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med (2004) 1.30
Exploring factors that influence informal caregiving in medication management for home hospice patients. J Palliat Med (2010) 1.28
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol (2005) 1.27
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med (2012) 1.25
Pursuing Excellence in Clinical Learning Environments. J Grad Med Educ (2016) 1.24
An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med (2010) 1.20
Geographic variation of spirometry use in newly diagnosed COPD. Chest (2008) 1.20
A community-based study of tobacco smoke exposure among inner-city children with asthma in Chicago. J Allergy Clin Immunol (2008) 1.19
Charcot arthropathy risk elevation in the obese diabetic population. Am J Med (2008) 1.18
Adequacy of medical chart review to characterize emergency care for asthma: findings from the Illinois Emergency Department Asthma Collaborative. Acad Emerg Med (2006) 1.17
Early Impressions of the CLER Program: A Survey of the Designated Institutional Official Community. J Grad Med Educ (2016) 1.17
Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Qual Saf Health Care (2007) 1.16
An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. Hum Mol Genet (2008) 1.15
Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med (2009) 1.13
Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine Tob Res (2008) 1.12
Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study. Cancer Epidemiol Biomarkers Prev (2009) 1.11
Patient-clinician communication: associations with important health outcomes among veterans with COPD. Chest (2010) 1.11
Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management. Acad Emerg Med (2010) 1.09
Differential enzymatic activity of common haplotypic versions of the human acidic Mammalian chitinase protein. J Biol Chem (2009) 1.08
At what age can children report dependably on their asthma health status? Pediatrics (2007) 1.06
Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD (2011) 1.06
Parent-reported environmental exposures and environmental control measures for children with asthma. Arch Pediatr Adolesc Med (2002) 1.04
Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med (2009) 1.04
Asthma burden in a citywide, diverse sample of elementary schoolchildren in Chicago. Ambul Pediatr (2007) 1.04
Patterns of healthcare utilization by COPD severity: a pilot study. Lung (2008) 1.04
Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2005) 1.03
Assessment of patient functional status after surgery. J Am Coll Surg (2005) 1.03